These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23581418)

  • 1. Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012.
    Ondrusova M; Mrozova L; Ondrus D; Mrinakova B
    Neoplasma; 2013; 60(4):446-51. PubMed ID: 23581418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing occurrence of urological cancers in Slovakia.
    Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A
    Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trends in Prostate Cancer Epidemiology in Slovakia - an International Comparison].
    Ondrušová M; Ondruš D
    Klin Onkol; 2017; 30(2):115-120. PubMed ID: 28397503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prostate cancer incidence and mortality before and after the introduction of PSA testing in the Slovak and Czech Republics.
    Ondrusova M; Ondrus D; Karabinos J; Muzik J; Kliment J; Gulis G
    Tumori; 2011; 97(2):149-55. PubMed ID: 21617707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
    Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer incidence and mortality in selected countries of Central Europe.
    Ondrusova M; Muzik J; Kliment J; Gulis G; Ondrus D
    Klin Onkol; 2011; 24(2):126-32. PubMed ID: 21638996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent patterns in stomach cancer descriptive epidemiology in the Slovak Republic with reference to international comparisons.
    Ondrusova M; Ondrus D
    Klin Onkol; 2011; 24(6):447-52. PubMed ID: 22257234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.
    Coldman AJ; Phillips N; Pickles TA
    CMAJ; 2003 Jan; 168(1):31-5. PubMed ID: 12515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].
    Bernal M; Romero FJ; Souza DL; Gómez-Bernal FJ; Gómez-Bernal GJ
    Actas Urol Esp; 2011 Sep; 35(8):470-4. PubMed ID: 21621302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of changing trends in prostate cancer incidence and mortality.
    Krongrad A; Lai S; Vidal EM
    Semin Urol Oncol; 1998 Feb; 16(1):30-4. PubMed ID: 9508080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of screening on prostate cancer rates and trends.
    Mettlin C
    Microsc Res Tech; 2000 Dec; 51(5):415-8. PubMed ID: 11074610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rising incidence and mortality of prostate cancer in Belgrade population.
    Janković J; Sipetić S
    Coll Antropol; 2011 Jun; 35(2):499-503. PubMed ID: 21755724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA testing in Austria: induced morbidity and saved mortality.
    Vutuc C; Waldhoer T; Lunglmayr G; Hoeltl W; Haidinger G
    Eur J Cancer Prev; 2009 Sep; 18(5):377-80. PubMed ID: 19512934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
    Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
    J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer incidence and mortality trends in 37 European countries: an overview.
    Bray F; Lortet-Tieulent J; Ferlay J; Forman D; Auvinen A
    Eur J Cancer; 2010 Nov; 46(17):3040-52. PubMed ID: 21047585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in prostate cancer testing and incidence among men under age of 50.
    Li J; German R; King J; Joseph D; Thompson T; Wu XC; Ajani U; Tai E
    Cancer Epidemiol; 2012 Apr; 36(2):122-7. PubMed ID: 22112545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
    Gilliland F; Becker TM; Smith A; Key CR; Samet JM
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in Czech Republic 1959-1992. Descriptive survey.
    Celko AM
    Cent Eur J Public Health; 1995 Aug; 3(3):119-23. PubMed ID: 8535365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends].
    Guérin S; Doyon F; Hill C
    Bull Cancer; 2009 Jan; 96(1):51-7. PubMed ID: 19211360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.